Portuguese pharma firm says best practice followed in French drug trial

January 15, 2016

Portuguese pharmaceutical company Bial insisted Friday that it had followed "international best practice" in a French drugs trial that has left one person brain-dead and five others hospitalised.

The company said in a statement it had followed "the applicable legislation" and that it would cooperate with the investigation underway to "determine in a rigorous and exhaustive manner" what happened.

The six victims, all men aged 28 to 49, had repeatedly taken the medication developed by Bial, which is intended to treat pain and such as anxiety.

"Our principal concern, at the moment, is taking care of participants in the trial," Bial said, particularly those who have been hospitalised.

The manufacturer said the product was an "inhibitor of the enzyme FAAH", or fatty acid amide hydrolase, which was being developed with "respect since the start for international best practice, with pre-clinical trials carried out, notably with respect to toxicology".

"This trial was approved by the regulatory authorities and the French ethics committee," the company said.

It added: "108 volunteers in good health participated in the testing of this new molecule without developing any adverse reaction, either moderate or serious."

French Health Minister Marisol Touraine had earlier said 90 people had been given the substance in variable doses.

Based in northern Portugal near the town of Porto, Bial says on its website that it is the country's largest pharmaceutical company, founded in 1924 with a presence in 58 countries.

It has produced treatments for a range of ailments including problems with the nervous system and cardiovascular health, as well as antibiotics and anti-allergens.

The drug test in France has been carried out since the summer by Biotral, a medical research company approved by the ministry, on behalf of the Portuguese .

Explore further: Botched French drug trial leaves 1 brain dead, 5 in hospital

Related Stories

Botched French drug trial leaves 1 brain dead, 5 in hospital

January 15, 2016
One man was brain dead and three others faced possible permanent brain damage after volunteering to take part in a trial for a painkiller and anxiety medication based on a natural brain compound similar to the active ingredient ...

Drugs trial tragedies: a rarity

January 15, 2016
Drugs trial tragedies like that reported in France on Friday which left one person brain dead and three others facing irreversible brain damage are a rarity, experts say.

Drug approval: How does it work?

January 15, 2016
The process of vetting experimental drugs is designed, with safety in mind, to be cautiously meticulous.

New cancer fears in France over breast implants (Update)

March 17, 2015
France's national cancer institute said on Tuesday there was a "clearly established link" between a rare form of cancer and a certain type of breast implant, as the health minister sought to allay fears.

Renault shares plunge after anti-fraud raids over emissions

January 14, 2016
Shares in Renault dived Thursday after French anti-fraud units conducted searches at the carmakers' facilities, prompted by the Volkswagen emissions scandal. They then recovered somewhat after the company said tests had not ...

Brazil authorizes dengue vaccine

December 28, 2015
Brazil became the first South American country Monday to authorize the world's first-ever dengue fever vaccine, which its French manufacturer says has the potential to save hundreds of lives here.

Recommended for you

In most surgery patients, length of opioid prescription, number of refills spell highest risk for misuse

January 17, 2018
The possible link between physicians' opioid prescription patterns and subsequent abuse has occupied the attention of a nation in the throes of an opioid crisis looking for ways to stem what experts have dubbed an epidemic. ...

Patients receive most opioids at the doctor's office, not the ER

January 16, 2018
Around the country, state legislatures and hospitals have tightened emergency room prescribing guidelines for opioids to curb the addiction epidemic, but a new USC study shows that approach diverts attention from the main ...

FDA bans use of opioid-containing cough meds by kids

January 12, 2018
(HealthDay)—Trying to put a dent in the ongoing opioid addiction crisis, the U.S. Food and Drug Administration on Thursday slapped strict new restrictions on the use of opioid-containing cold and cough products by kids.

Taking ibuprofen for long periods found to alter human testicular physiology

January 9, 2018
A team of researchers from Denmark and France has found that taking regular doses of the pain reliever ibuprofen over a long period of time can lead to a disorder in men called compensated hypogonadism. In their paper published ...

Nearly one-third of Canadians have used opioids: study

January 9, 2018
Nearly one in three Canadians (29 percent) have used "some form of opioids" in the past five years, according to data released Tuesday as widespread fentanyl overdoses continue to kill.

Growing opioid epidemic forcing more children into foster care

January 8, 2018
The opioid epidemic has become so severe it's considered a national public health emergency. Addiction to prescription painkillers, such as oxycodone and morphine, has contributed to a dramatic rise in overdose deaths and ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.